Latest Financial Health News

Elsight reported a robust 32% increase in annual revenue for 2024, driven by a strategic pivot towards the defense sector, which now accounts for over half of its total revenue. The company’s expanding customer base and debt elimination position it well for growth in 2025.

Bindi Metals reports a significant 3.3 km by 0.6 km antimony soil anomaly at its Kreva prospect in Serbia, alongside steady progress on the Lisa Project application and a solid cash position of $1.866 million.

Triton Minerals has secured A$17 million from the sale of a 70% stake in its Mozambique graphite assets, while progressing environmental approvals and unveiling promising high-grade gold and copper results at its new Aucu project.

GBM Resources reports robust progress in its Queensland and South Australian gold projects, highlighted by a $12 million farm-in deal at Twin Hills and positive cash flow from White Dam. Exploration strategies and corporate restructuring set the stage for a pivotal 2025.

Voltaic Strategic Resources reports significant gold and poly-metallic mineralisation at its Kooline and Meekatharra projects, alongside a strategic board restructure and a robust cash position of $5.4 million.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Tribune Resources Limited has announced an on-market buy-back of up to 5.25 million shares, signaling confidence in its capital structure and aiming to enhance shareholder value over the next year.

Freehill Mining Ltd’s December quarter cash flow report reveals a $114,000 net cash outflow from operations but highlights a solid liquidity position with $301,000 in unused financing facilities.

Kinetiko Energy reports mixed results from its five-well gas production test program, with the first well underperforming but the company maintaining optimism for the remaining wells and a strong financial footing.

Emperor Energy Limited reported a net operating cash outflow of $376,000 for the December quarter but bolstered its cash reserves with a $3.6 million financing inflow, ending the period with $3.4 million in cash.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.